Rocket Doctor AI (AIDR:CA)
Fundamental Research initiated coverage on Rocket Doctor AI with a “Buy” rating and a 12 month target price forecast of $2.10 per share. The initiation reflects optimism around the company’s role in the rapidly expanding digital healthcare and telemedicine space, where demand for remote, technology-enabled medical services continues to accelerate.
Fundamental Research’s assessment highlights Rocket Doctor AI’s platform-driven model, which leverages artificial intelligence to improve patient access, streamline physician workflows, and enhance care delivery efficiency. The firm views the company’s technology as well aligned with healthcare system pressures, including physician shortages, rising costs, and the need for scalable virtual care solutions. Growth potential is seen in expanding partnerships, increased patient adoption, and broader acceptance of telehealth across both public and private healthcare settings.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.
